高级检索
当前位置: 首页 > 详情页

Multifunctional Magnetic Nanoagents for Bioimaging and Therapy

文献详情

资源类型:
WOS体系:
Pubmed体系:

收录情况: ◇ EI ◇ ESCI

机构: [1]Longgang E.N.T. Hospital and Shenzhen Key Laboratory of E.N.T., Institute of E.N.T., Shenzhen, Guangdong 518116, China [2]Guangdong Provincial Key Laboratory of Malignant Tumor Epigenetics and Gene Regulation, Guangdong-Hong Kong Joint Laboratory for RNA Medicine, Medical Research Center, Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University, Guangzhou 510120, China [3]Science and Technology Innovation Center, Guangzhou University of Chinese Medicine, Guangzhou 510405, China [4]Center for Precision Medicine, Sun Yat-Sen University, Guangzhou 510080, China
出处:
ISSN:

关键词: multifunctional magnetic nanoagents (MMNs) multimodal imaging combination therapy nanomedicine image-guided cancer therapy

摘要:
Multifunctional magnetic nanoagents (MMNs) have drawn increasing attention in cancer precision therapy, attributed to their good biocompatibility and the potential applications for multimodal imaging and multidisciplinary therapy. The noble metal or isotopes contained in MMNs could not only perform superparamagnetism, providing an outstanding magnetic targeting property for drug delivery, but also endow the MMNs with a magnetocaloric effect, photothermal performance, and radiotherapy sensitization, arriving at a multimode combination therapy for cancer. Also, the composite component can endow MMNs with various imaging performance, such as magnetic resonance imaging (MRI), computed tomography (CT), positron emission tomography (PET), and single-photon emission computed tomography (SPECT), thereby achieving accurate image-guided therapy for cancer. However, the joint function of MMNs is closely correlated with their functional nanocomponents and nanostructures. In this article, we will systematically discuss the design, synthesis, and structure optimization of MMNs, as well as their potential in multimodal diagnosis and therapy, scientifically providing an integrated diagnosis and treatment of nanomedicine for the future cancer therapy.

基金:
语种:
被引次数:
WOS:
PubmedID:
中科院(CAS)分区:
出版当年[2020]版:
最新[2025]版:
大类 | 3 区 材料科学
小类 | 4 区 材料科学:生物材料 4 区 纳米科技
JCR分区:
出版当年[2019]版:
最新[2023]版:
Q2 MATERIALS SCIENCE, BIOMATERIALS Q2 NANOSCIENCE & NANOTECHNOLOGY

影响因子: 最新[2023版] 最新五年平均 出版当年[2019版] 出版当年五年平均 出版前一年[2018版]

第一作者:
第一作者机构: [1]Longgang E.N.T. Hospital and Shenzhen Key Laboratory of E.N.T., Institute of E.N.T., Shenzhen, Guangdong 518116, China [2]Guangdong Provincial Key Laboratory of Malignant Tumor Epigenetics and Gene Regulation, Guangdong-Hong Kong Joint Laboratory for RNA Medicine, Medical Research Center, Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University, Guangzhou 510120, China
通讯作者:
通讯机构: [1]Longgang E.N.T. Hospital and Shenzhen Key Laboratory of E.N.T., Institute of E.N.T., Shenzhen, Guangdong 518116, China [2]Guangdong Provincial Key Laboratory of Malignant Tumor Epigenetics and Gene Regulation, Guangdong-Hong Kong Joint Laboratory for RNA Medicine, Medical Research Center, Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University, Guangzhou 510120, China [4]Center for Precision Medicine, Sun Yat-Sen University, Guangzhou 510080, China
推荐引用方式(GB/T 7714):
APA:
MLA:

资源点击量:2018 今日访问量:0 总访问量:645 更新日期:2024-07-01 建议使用谷歌、火狐浏览器 常见问题

版权所有©2020 广东省中医院 技术支持:重庆聚合科技有限公司 地址:广州市越秀区大德路111号